Cargando…

Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products

Detalles Bibliográficos
Autores principales:	Manian, Deepti Vellaichamy, Jensen, Chelsee, Theel, Elitza S., Mills, John R., Joshi, Avni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834008/ https://www.ncbi.nlm.nih.gov/pubmed/33232829 http://dx.doi.org/10.1016/j.anai.2020.11.009

Ejemplares similares

Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
por: Theel, Elitza S.
Publicado: (2022)

Predictors of seroconversion after coronavirus disease 2019 vaccination
por: Chiarella, Sergio E., et al.
Publicado: (2022)

Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
por: Squire, Jacqueline D., et al.
Publicado: (2021)

Predictors Of Seroconversion Following COVID-19 Vaccination
por: Chiarella, Sergio, et al.
Publicado: (2022)

Evaluation of the genalyte maverick SARS-CoV-2 multi-antigen serology panel
por: Donato, Leslie J., et al.
Publicado: (2021)

Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
por: Larkey, Nicholas E., et al.
Publicado: (2022)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area
por: Shah, Vishal P., et al.
Publicado: (2020)

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration
por: Fiedler, Sebastian, et al.
Publicado: (2022)

Molecular and Direct Detection Tests for Treponema pallidum Subspecies pallidum: A Review of the Literature, 1964–2017
por: Theel, Elitza S, et al.
Publicado: (2020)

Trends in Q fever serologic testing by immunofluorescence from four large reference laboratories in the United States, 2012–2016
por: Miller, Halie K., et al.
Publicado: (2018)

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
por: Klingler, Jéromine, et al.
Publicado: (2020)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Diagnostic Testing for Zika: Observing Rapid Translation During a Public Health Emergency
por: Kurani, Shaheen, et al.
Publicado: (2017)

Serological survey on canine coronavirus antibodies in giant pandas by virus neutralization test
por: Jun, Qiao, et al.
Publicado: (2004)

Serological prevalence of canine respiratory coronavirus
por: Priestnall, Simon L., et al.
Publicado: (2006)

Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries
por: Hashmi, Shahrukh K., et al.
Publicado: (2020)

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
por: Theel, Elitza S., et al.
Publicado: (2020)

339. Assessing Utilization of the Venereal Disease Research Laboratory Test in Cerebrospinal Fluid for the Diagnosis of Neurosyphilis: A Cohort Study
por: Sytsma, Terin, et al.
Publicado: (2020)

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
por: Muecksch, Frauke, et al.
Publicado: (2020)

Product Choice Affects Risk of False-Positive Hepatitis B Virus Serology During Immunoglobulin Replacement Therapy
por: Lindahl, Hannes, et al.
Publicado: (2023)

Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and perspectives
por: Vieira, Marcelo Adriano da Cunha e Silva, et al.
Publicado: (2020)

The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable
por: Jensen, Chelsee
Publicado: (2021)

Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy
por: Cox, Fionnuala, et al.
Publicado: (2021)

Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
por: Hassin, Ori, et al.
Publicado: (2021)

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Upasani, Vinit, et al.
Publicado: (2023)

Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection
por: Torii, Yuka, et al.
Publicado: (2019)

Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus
por: Pan, Xiaoyan, et al.
Publicado: (2020)

Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe( )
por: Farcet, Maria R, et al.
Publicado: (2022)

753. Performance Characteristics of Diagnostic Assays in Blastomycosis
por: O’Dowd, Timothy, et al.
Publicado: (2020)

Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes
por: Valencia Sanchez, Cristina, et al.
Publicado: (2021)

Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
por: Harvey, Ruth, et al.
Publicado: (2019)

Serological and molecular evidence that canine respiratory coronavirus is circulating in Italy
por: Decaro, Nicola, et al.
Publicado: (2007)

Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study
por: McDade, Thomas W, et al.
Publicado: (2022)

Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency
por: Squire, Jacqueline, et al.
Publicado: (2021)

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
por: Compagno, Nicolò, et al.
Publicado: (2014)

An Unusual Cluster of Neuroinvasive Lyme Disease Cases Presenting With Bannwarth Syndrome in the Midwest United States
por: Shah, Aditya, et al.
Publicado: (2017)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic( )
por: Farcet, Maria R, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies
por: Gaber, Yasmine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9a3vuem4lbjb4aeu2fbq0d9mg5